Dr. Steven Kalkanis, Neurosurgery Chair, Elected a Director of ABNS

Dr. Steven N. Kalkanis, Chair of the Department of Neurosurgery at Henry Ford Health System and Medical Director of the Henry Ford Cancer Institute, has been elected a director of the American Board of Neurological Surgery. (Photo: Henry Ford Health System)

DETROIT, MI – Dr. Steven N. Kalkanis, Chair of the Department of Neurosurgery at Henry Ford Health System and Medical Director of the Henry Ford Cancer Institute, has been elected a director of the American Board of Neurological Surgery (ABNS). His six-year term began in July 2018.

ABNS is a non-profit public safety organization dedicated to the protection of patients and the education and elevation of all board certified neurological surgeons. The ABNS is responsible for ongoing professional certification activities including the development and administration of board certification examinations, credentialing, professionalism review and continuous certification for neurosurgeons.

Chair of the ABNS Board of Directors, Dr. Richard G. Ellenbogen, said, “We are honored and thrilled to welcome Dr. Kalkanis as one of the newest members of our board of directors. The directors who are nominated, accepted and ultimately elected to the board are elite academicians and educators. The uncompensated service Dr. Kalkanis will perform over the next six years will be focused on maintaining the highest standards of the practice of Neurological Surgery. As an internationally recognized tumor surgeon and leader in American Neurological Surgery, Dr. Kalkanis will no doubt contribute in significant ways.”

Dr. Kalkanis is recognized as a leader in brain and spinal cord tumors, intracranial and stereotactic neurosurgery, and adult cervical and lumbar spine disease. He wanted to become a doctor from a very young age, he said in a video on the Henry Ford Health System website. An internationally recognized expert in brain tumor surgery, Dr. Kalkanis authored the definitive set of guidelines for the multidisciplinary treatment of brain metastases.

He has published extensively on the topic of brain tumors in many prestigious medical journals, and regularly presents his research findings at some of the nation’s top medical meetings.

Dr. Kalkanis has held many esteemed positions, including his current position as President-Elect of the Congress of Neurological Surgeons, the largest neurosurgical association in the world, and Past-Chair of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. He also served as President of the Michigan Association of Neurological Surgeons.

Dr. Kalkanis received his undergraduate degree from Harvard University, graduating with highest honors with the distinction of a John Harvard Scholar. He then earned his medical degree from Harvard Medical School, receiving the Linnane Prize for highest overall achievement and serving as Class Marshal. He was recruited to Henry Ford in 2004 after completing his residency training at the Harvard – Massachusetts General Hospital program.

Dr. Kalkanis is Chair of the Henry Ford Department of Neurosurgery, a nationally recognized academic center for research and clinical excellence with 33 physicians and scientists, and he also serves as Co-Director of the Neuroscience Institute.

In addition, he leads 1,300 cancer physicians, nurses, scientists and administrators as Medical Director of the Henry Ford Cancer Institute, which has been recognized for innovations ranging from precision medicine and advanced clinical trials to MRI-guided radiation therapy.

More information about the Henry Ford Department of Neurosurgery is available online: henryford.com.